Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
CDK inhibitor.
Tocopherol analog
Azalide macrolide; protein translation inhibito...
PI3K inhibitor.
HIV protease inhibitor, SERCA inhibitor.
Type A trichothecene mycotoxin produced by Fusa...
Endogenous organosulfur also found in meat and ...
Endogenous NMDA receptor antagonist.
5-α-Reductase inhibitor.
Triterpenoid
DOPA decarboxylase inhibitor, indirect α2-adre...
EGFR inhibitor.
JNK, ALK, p38 MAPK inhibitor.
Rifamycin derivative, induces pore formation in...
Aureothricin is a member of the dithiolopyrrolo...
NSAID; COX-1/2 inhibitor.
MAO-A/B inhibitor.
Kavalactone originally found in Piper methystic...
Non-opioid analgesic.
Neuraminidase inhibitor.